{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:52:34Z","timestamp":1787017954749,"version":"build-2736575974"},"reference-count":42,"publisher":"S. Karger AG","issue":"6","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/karger.com\/pages\/terms-and-conditions"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/karger.com\/pages\/terms-and-conditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncology"],"abstract":"<jats:p>Introduction: The prognosis of patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer has improved with the introduction of oral EGFR-tyrosine kinase inhibitor (TKI). Lower adherence to oral anticancer medications is reportedly associated with a poor prognosis. It is important to understand the causes of lower adherence to oral anticancer medications. We aimed to assess the potential risk factors associated with low adherence to EGFR-TKIs in a real-world clinical setting using administrative claims data in Japan. Methods: We identified 10,809 outpatients routinely prescribed EGFR-TKIs between December 2015 and January 2023. Adherence to EGFR-TKIs was assessed based on the medication possession ratio (MPR) during the 12-month follow-up period from the date of first outpatient EGFR-TKI prescription. Multivariable linear regression analysis was performed to identify the potential risk factors associated with lower adherence. Results: The mean (standard deviation) MPR was 94.1% (14.0). Lower adherence was associated with increasing age (per 10-year increase), female sex, dysphagia, and a higher number of concomitant oral medications (per doubling of the count). Conclusion: Adherence to EGFR-TKIs was generally high, but the findings support tailored adherence strategies, especially for older patients and for those with a higher number of concomitant oral medications, including medication review to reduce pill burden and proactive support for swallowing difficulties.<\/jats:p>","DOI":"10.1159\/000548812","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T16:01:13Z","timestamp":1760371273000},"page":"703-712","source":"Crossref","is-referenced-by-count":4,"title":["Risk Factors for Lower Adherence to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors for Non-Small Cell Lung Cancer: A Nationwide Retrospective Cohort Study in Japan"],"prefix":"10.1159","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2538-6328","authenticated-orcid":false,"given":"Yasutaka","family":"Ihara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"127","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1099314"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-011110-130206"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00444-8"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1612674"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2012.11.007"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5414\/CP204259"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040938"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909530"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70604-1"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-015-0843-2"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170651"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-018-5050-1"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2019.12.003"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1713137"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600591"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/1533317518787314"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1159\/000448717"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2007.00213.x"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(94)90129-5"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2021.21310"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2023.2243220"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/metabo13101087"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.1.110"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.52.9123"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2018.12.026"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k3532"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-024-09136-4"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.14180"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.schbul.a007071"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70393-X"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2393"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2017.12.003"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyx087"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxab392"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61571-5"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2023.03.007"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyae094"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2016.019729"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2019.1699519"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-018-0127-0"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4856"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1248\/yakushi.23-00194"}],"container-title":["Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/karger.com\/article-pdf\/doi\/10.1159\/000548812","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:04:21Z","timestamp":1780329861000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000548812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,1]]},"published-print":{"date-parts":[[2026,6,3]]}},"URL":"https:\/\/doi.org\/10.1159\/000548812","archive":["Portico"],"relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.6084\/m9.figshare.30327712","asserted-by":"subject"}]},"ISSN":["0030-2414","1423-0232"],"issn-type":[{"value":"0030-2414","type":"print"},{"value":"1423-0232","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]}}}